pindolol has been researched along with isradipine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 15 (55.56) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Balazovjech, I; Dzúrik, R; Fet'kovská, N; Kvasnicka, J; Lupínek, Z; Mayer, O; Pidrman, V; Widimský, J | 1 |
| Balazovjech, I; Dzúrik, R; Fetkovská, N; Kvasnicka, J; Lupínek, Z; Mayer, O; Pidrman, V; Widimský, J | 1 |
| Borbás, S; Lengyel, M; Török, E; Zorándi, A | 1 |
| Blaha, M; Dvorák, I; Nĕmcová, H | 1 |
| Dvorák, I; Dzúrik, R; Fetkovská, N; Jonás, P; Kotlík, I; Markuljak, I; Petr, P; Widimský, J | 1 |
| Bristow, MR; Minobe, W; Rasmussen, RP | 1 |
| Andrén, L; Aurell, M; Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Sievert, A; Svensson, A | 1 |
| Aström, B; Dahlöf, B; Frithz, G; Hansson, L; Himanen, P; Sundstedt, CD; Tollin, C | 1 |
| Hof, RP | 1 |
| Dahlof, B; Hansson, L | 1 |
| Andrén, L; Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Svensson, A | 1 |
| Lüscher, TF; Waeber, B | 1 |
| Fitscha, P; Magometschnigg, D; Meisner, W | 1 |
| Farsang, C; Holló, J; Jávor, T; Kapocsi, J; Kerkovits, G; Kiss, I; Török, E | 1 |
| Berne, C; Lind, L; Lithell, H; Pollare, T | 1 |
| Böhm, M; Erdmann, E; Koch, A; Morano, I; Rüegg, JC; Schwinger, RH | 1 |
| Fitscha, P; Meisner, W | 1 |
| Kragie, L; Kwon, YW; Smiehorowski, R | 1 |
| Magometschnigg, D | 1 |
| Hansson, L | 1 |
2 review(s) available for pindolol and isradipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Isradipine: a profile in essential hypertension.
Topics: Animals; Captopril; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Pindolol; Quality of Life | 1993 |
13 trial(s) available for pindolol and isradipine
| Article | Year |
|---|---|
[Multicenter study of isradipine in the treatment of hypertension].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol | 1992 |
MIS (Multicentric Isradipine Study of antihypertensive therapy).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol | 1992 |
Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cardiomegaly; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Ventricular Function, Left | 1992 |
Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Pyridines; Rest | 1991 |
Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cholesterol; Clinical Trials as Topic; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Pyridines; Smoking | 1990 |
Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Calcium; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Oxadiazoles; Pindolol; Random Allocation | 1987 |
Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Placebos; Pyridines | 1989 |
Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Oxadiazoles; Pindolol; Random Allocation | 1987 |
The long-term effect of isradipine in pindolol-treated patients.
Topics: Aged; Body Weight; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Pyridines | 1987 |
Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial.
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Metolazone; Middle Aged; Pindolol | 1993 |
A multicenter study using causal readings, self-recordings, and ambulatory blood pressure monitoring to assess isradipine effects. AMICUS Study Group.
Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Isradipine; Male; Middle Aged; Pindolol; Self Care | 1994 |
Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Lipids; Longitudinal Studies; Middle Aged; Pindolol | 1994 |
Isradipine in the treatment of mild-to-moderate hypertension. The Austrian Multicenter Isradipine cum Spirapril Study (AMICUS).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Treatment Outcome | 1993 |
12 other study(ies) available for pindolol and isradipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Topics: Calcium Channel Blockers; Calcium Channels; Cardiomyopathy, Dilated; Cell Membrane; Humans; Iodocyanopindolol; Isradipine; Kinetics; Myocardium; Nitrendipine; Oxadiazoles; Pindolol; Receptors, Adrenergic, beta; Receptors, Nicotinic | 1990 |
Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Consciousness; Drug Interactions; Hemodynamics; Humans; Isradipine; Oxadiazoles; Pindolol; Propranolol; Rabbits; Verapamil | 1987 |
Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment.
Topics: Adult; Blood Glucose; Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Hemoglobin A; Humans; Hypertension; Insulin; Isradipine; Lipoproteins; Male; Middle Aged; Pindolol; Time Factors | 1994 |
Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
Topics: Adult; Calcium Channels; Diacetyl; Female; Heart; Humans; In Vitro Techniques; Iodocyanopindolol; Isradipine; Male; Middle Aged; Myocardial Contraction; Ouabain; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Sodium-Potassium-Exchanging ATPase | 1994 |
Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement.
Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol | 1994 |
Rat cardiac calcium channels and their relationships with beta-adrenergic and muscarinic receptors in hypothyroidism.
Topics: Animals; Calcium; Calcium Channels; Carbachol; Dose-Response Relationship, Drug; Heart Rate; Hypothyroidism; Iodocyanopindolol; Isoproterenol; Isradipine; Male; Myocardial Contraction; Myocardium; Pindolol; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Muscarinic; Thyroidectomy; Thyroxine | 1993 |